Correction: Overexpression of CIP2A is associated with poor prognosis in multiple myeloma
Xuewen Liu(Peking University), Ying Liu(Kunming University of Science and Technology), Junnian Zheng(Xuzhou Medical College), Pinghong Ming(Hubei University of Chinese Medicine), Wei Cao(Academy of Military Medical Sciences), Te Zhang(Hubei University of Medicine), Baofu Zhang(Xuzhou Medical College), Lu Zheng(Beijing Institute of Technology), Guo Yang(Hubei University of Medicine), Ying Dong(Second Affiliated Hospital of Zhejiang University), Shanshan Qin(Hubei University of Medicine)
Cited by 1
Related Papers
Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable <i>MET</i> Gene Mutations
|Journal of Clinical Oncology|2015|343
Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
|Oncotarget|2018|217
Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke
|JAMA|2023|209
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
|Cancer Letters|2014|189
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
|Frontiers in Immunology|2024|136